Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation

BACKGROUND: To evaluate the impact of targeted agents in stage II-III rectal cancer undergoing neoadjuvant concurrent chemoradiation therapy (CCRT). METHOD: A retrospective study was performed in 124 consecutive patients with clinically T(3)N(0-2)M(0)-staged rectal cancer incorporating targeted agen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Liang, Jin-Tung, Chen, Tzu-Chun, Huang, John, Jeng, Yung-Ming, Cheng, Jason Chia-Hsien
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731917/
https://ncbi.nlm.nih.gov/pubmed/29254207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21762
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller